Cyclerion Therapeutics, Inc. ( CYCN) - Key Metrics
CYCN Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | $0.27 | -$0.30 | -$0.08 | -$0.08 |
| 2025Q2 | $0.03 | -$0.11 | -$0.16 | -$0.16 |
| 2025Q1 | $0.03 | -$0.56 | -$0.38 | -$0.38 |
CYCN Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | -1.90 |
| 2025Q2 | ? | -6.90 |
| 2025Q1 | ? | -1.12 |
CYCN
Price: $3.63
52 week price:
Earnings Per Share: -1.31 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 146600
Market Capitalization: 14.9 million